Ficus dubia Latex Extract Induces Cell Cycle Arrest and Apoptosis by Regulating the NF-κB Pathway in Inflammatory Human Colorectal Cancer Cell Lines
Open Access
Abstract
Colorectal cancer is one of the most diagnosed cancers that is associated with inflammation. Ficus dubia latex is recognized as a remedy with various therapeutic effects in traditional medicine, including anti-inflammatory and antioxidant activity. The present study aims to compare the anti-tumor activity of Ficus dubia latex extract (FDLE) against HCT-116 and HT-29 human colorectal cancer cell lines in normal and inflammatory condition and explore its mechanism of action. FDLE exhibited remarkable antiproliferative activity against HCT-116 and HT-29 colorectal cancer cell lines in both conditions using MTT and colony formation assays and more effective anti-proliferation was observed in inflammatory condition. Mechanistically, FDLE induced cell cycle arrest at G0/G1 phase by down-regulating NF-κB, cyclin D1, CDK4 and up-regulatingp21 in both cell in normal condition. In inflammatory condition, FDLE not only exhibited stronger induction of cell cycle arrest in both cells by down-regulating NF-κB, cyclin D1, CDK4 and down-regulating p21, but also selectively induced apoptosis in HCT-116 cells by down-regulating NF-κB and Bcl-xl and up-regulating Bid, Bak, cleaved caspase-7 and caspase-3 through stronger ability to regulate these proteins. Our results demonstrated that the phytochemical agent in the latex of Ficus dubia could potential be used for treatment and prevention of human colorectal cancer, especially in inflammation-induced hyperproliferation progression.Keywords
Funding Information
- The Agricultural Research Development Agency (Public Organization) (CRP6105022130)
This publication has 44 references indexed in Scilit:
- The anticancer effect of saffron in two p53 isogenic colorectal cancer cell linesBMC Complementary and Alternative Medicine, 2012
- Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell linesClinical & Experimental Metastasis, 2012
- Intestinal Inflammation and CancerGastroenterology, 2011
- Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin DAnnual Review of Pharmacology and Toxicology, 2011
- Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cellsInvestigational New Drugs, 2011
- NF-κB Signaling Pathway, Inflammation and Colorectal CancerCellular & Molecular Immunology, 2009
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007
- Cytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer2006
- NF-kB in development and progression of human cancerVirchows Archiv, 2005
- Mutation analysis of p53, K‐ras, and BRAF genes in colorectal cancer progressionJournal of Cellular Physiology, 2005